Anandita Agarwala
Overview
Explore the profile of Anandita Agarwala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Revankar S, Park J, Satish P, Agarwala A
Am J Prev Cardiol
. 2024 Feb;
17:100639.
PMID: 38419948
As the global population ages and cardiovascular risk factors rise, we can expect a continued increase in atherosclerotic disease. Low-density lipoprotein cholesterol (LDL-C) reduction is a cornerstone of cardiovascular risk...
12.
Sheidu M, Agarwala A, Lakshmanan S, Honigberg M, Spitz J, Sharma G
Heart
. 2024 Jan;
111(2):83-92.
PMID: 38233160
No abstract available.
13.
Agarwala A, Satish P, Al Rifai M, Mehta A, Cainzos-Achirica M, Shah N, et al.
JACC Adv
. 2023 Dec;
2(2).
PMID: 38089916
South Asians (SAs, individuals with ancestry from Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, and Sri Lanka) are among the fastest growing ethnic subgroups in the United States. SAs typically experience...
14.
Agarwala A, Patel J, Stephens J, Roberson S, Scott J, Beckie T, et al.
Circulation
. 2023 Sep;
148(15):1183-1193.
PMID: 37698007
Prevention of cardiovascular and related diseases is foundational to attaining ideal cardiovascular health to improve the overall health and well-being of individuals and communities. Social determinants of health and health...
15.
Charitha Koneru S, Sikand G, Agarwala A
Am J Cardiol
. 2023 Jul;
203:113-121.
PMID: 37487405
South Asians are at an elevated risk of atherosclerotic cardiovascular disease (ASCVD) when compared with other age-matched subjects of varied ethnicities. The elevated ASCVD risk is multifactorial including a constellation...
16.
Kalra D, Vorla M, Michos E, Agarwala A, Virani S, Duell P, et al.
J Am Coll Cardiol
. 2023 Jul;
82(2):171-181.
PMID: 37407116
The advent of newer and better tolerated antiretroviral therapy has progressively shortened the life expectancy gap between people living with HIV (PWH) and the general population. However, in this aging...
17.
Park J, Balarbar N, Agarwala A
Curr Cardiol Rep
. 2023 Jul;
25(9):969-978.
PMID: 37405598
Purpose Of Review: To provide an updated review of bempedoic acid's clinical application in lowering LDL-C in the setting of statin intolerance and the recent findings in the CLEAR Outcomes...
18.
19.
Agarwala A, Ballantyne C, Goldberg A
J Clin Lipidol
. 2023 Mar;
17(2):304-305.
PMID: 36965960
No abstract available.
20.
Agarwala A, Patel J, Blaha M, Cainzos-Achirica M, Nasir K, Budoff M
Am J Prev Cardiol
. 2023 Jan;
13:100455.
PMID: 36636123
South Asian (SA) individuals, particularly those that reside in the United States and other Westernized countries, are at an elevated risk for ASCVD and mortality related to ASCVD. The 2018...